Adenocarcinoma of the urinary bladder

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 12, 2011, Pages 1601-1605

  Roy, Somak ^a   Parwani, Anil V ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; BETA CATENIN; CDX2 PROTEIN, HUMAN; CK 34 BETA E12; CK-34 BETA E12; CTNNB1 PROTEIN, HUMAN; CYTOKERATIN 20; CYTOKERATIN 7; HOMEODOMAIN PROTEIN; KERATIN; THBD PROTEIN, HUMAN; THROMBOMODULIN; VILLIN;

ADENOCARCINOMA; BLADDER TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REVIEW;

ADENOCARCINOMA; BETA CATENIN; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; KERATINS; MICROFILAMENT PROTEINS; THROMBOMODULIN; URINARY BLADDER NEOPLASMS;

EID: 82655184645     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2009-0713-RS     Document Type: Review

References (28)

1. Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordóñez NG. Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases. Cancer. 1991;67(8):2165-2172.
2. Epstein JI, Amin MB, Reuter VE. Glandular lesions. In: Epstein JI, Amin MB, Reuter VE, eds. Bladder Biopsy Interpretation: Biopsy Interpretation Series. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010:150-176.
3. Bostwick DG, Cheng L. Neoplasms of the urinary bladder. In: Bostwick DG, Cheng L. Urologic Surgical Pathology. 2nd ed. Philadelphia, PA: Mosby; 2008: 300-307.
4. Morton MJ, Zhang S, Lopez-Beltran A, et al. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res. 2007;13(20):6232-6236. (Pubitemid 350075085)
5. Sung MT, Lopez-Beltran A, Eble JN, et al. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol. 2006; 19(11):1395-1401. (Pubitemid 44624156)
6. Bollito ER, Pacchioni D, Lopez-Beltran A, et al. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumor of urinary bladder. Anal Quant Cytol Histol. 2005;27(4):218-224. (Pubitemid 41233498)
7. Shaaban AA, Elbaz MA, Tribukait B. Primary non-urachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization of 93 cases. Urology. 1998;51(13):469-476. (Pubitemid 28136688)
8. El-Merkresh MM, El-Baz MA, Abol-Enein H, Ghoneim MA. Primary adenocarcinoma of urinary bladder: a report of 185 cases. Br J Urol. 1998; 82(2):206-212.
9. Melicow MM. Tumor of the urinary bladder: a clinicopathological analysis of over 2500 specimens and autopsies. J Urol. 1955;74(4):498-521.
10. Poore TE, Egbert B, Jahnke R, Kraft JK. Signet ring cell adenocarcinoma of the bladder: linitis plastic variant. Arch Pathol Lab Med. 1981;105(4):203-204. (Pubitemid 11152297)
11. Sordo RD, Bellezza G, Colella R, Mameli MG, Sidoni A, Cavaliere A. Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases. Appl Immunohistochem Mol Morphol. 2009;17(1):18-22.
12. Grignon DJ, Ro JY, Ayala AG, Johnson DE. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol. 1991;95(1):13-20.
13. Gaafar A, Garmendia M, de Miguel E, et al. Plasmacytoid urothelial carcinoma of the urinary bladder: a study of 7 cases. Actas Urol Esp. 2008;32(8): 806-810.
14. Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol. 2009;22(suppl 2):S96-S118.
15. Wang HL, Lu DW, Yerian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25(11):1380-1387. (Pubitemid 33022053)
16. Torenbeek R, Lagendijk JH, Van Diest PJ, Bril H, van de Molengraft FJ, Meijer CJ. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology. 1998;32(1): 20-27.
17. Suhl N, Yang XJ, Tretiakova MS, Humphrey PA, Wang HL. Value of CDX2, villin, and a-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol. 2005;18(9):1217-1222. (Pubitemid 43079921)
18. Raspollini MR, Nesi G, Baroni G, Girardi LR, Taddei GL. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol. 2005;13(4):358-362. (Pubitemid 41697399)
19. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin and immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27(3):303-310. (Pubitemid 36245795)
20. Tamboli P, Mohsin SK, Hailemariam S, Amin MB. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med. 2002;126(9):1057-1063. (Pubitemid 36221843)
21. Gopalan A, Sharp DA, Fine SW, et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol. 2009; 33(5):659-668.
22. Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40(1):108-116.
23. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol. 1984;131(1):1-8. (Pubitemid 14218075)
24. Oliva E, Amin MB, Jimenez R, Young RH. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26(2):190-197. (Pubitemid 34127498)
25. Adeniran AJ, Tamboli P. Clear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med. 2009;133(6):987-991.
26. Peven DR, Hidvegi DF. Clear-cell adenocarcinoma of the female urethra. Acta Cytol. 1985;29(2):142-146. (Pubitemid 15083857)
27. Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol. 1998; 29(12):1451-1456. (Pubitemid 28563979)
28. Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003;442(4): 381-387. (Pubitemid 36561096)